InvestorsHub Logo
Followers 36
Posts 1166
Boards Moderated 0
Alias Born 03/07/2013

Re: None

Tuesday, 10/13/2015 10:43:54 AM

Tuesday, October 13, 2015 10:43:54 AM

Post# of 118395
Most promising line of PR is:

Dr. Lander will also be involved in the establishment of non-dilutive financial collaborations to further the Company's growth.



The most troubling is: Why is he no longer a part of Sidra when the hospital plan he was "overseeing" is not to open until 2018. I went to Sidra's website and could not find his name listed. Why is he leaving? Was he fired? Why does he become RGBP President a day after being added to TSI SAB with responsibility of overseeing their development.

Are these just "names for hire"?

Obviously these guys make a lot of connections at this scientific conventions like the meeting on the Mesa. Just hope he is not in it for the quick buck. Cavens was given a ton of shares to make the financial connections and development for the company. Now we add Lander to do so.

I hope this doesn't become a revolving door.

More interesting is Jack's statement of buying shares and saying toay's PR is huge. I don't see today's PR as huge until there are results and Lander won't even take on any responsibility until a month from now.

FDA approval PR for HemaX would be huge. Adding another person who is part of many companies at a large salary is potentially huge if he is able to produce something, but being on scientific boards of other startups with no money is not the connections we are looking for.

Anyone who finds more info on Landers that can fill in some of our questions, most grateful if you can post for all.

Waiting for concrete news.